Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site #001052
Cullman, Alabama, United States
- Facility name not stated
Scottsdale, Arizona, United States
- Site # 001974
Tucson, Arizona, United States
- Site #001046
Encinitas, California, United States
- Site # 001822
Fountain Valley, California, United States
- Site # 001852
La Jolla, California, United States
- Merz Investigative Site #001986
Los Angeles, California, United States
- Site # 001924
Los Gatos, California, United States
- Site # 001005
Newport Beach, California, United States
- Site # 001973
Sacramento, California, United States
- Site # 001977
New Haven, Connecticut, United States
- Site # 001901
Washington D.C., District of Columbia, United States
- Site # 001803
Boca Raton, Florida, United States
- Site # 001805
North Palm Beach, Florida, United States
- Site # 001955
Sarasota, Florida, United States
- Site # 001823
St. Petersburg, Florida, United States
- Site # 001972
Chicago, Illinois, United States
- Site #001057
Glenview, Illinois, United States
- Site #001978
Lake Bluff, Illinois, United States
- Site # 001820
Winfield, Illinois, United States
- Site # 001995
Munster, Indiana, United States
- Site # 001833
Overland Park, Kansas, United States
- Site # 001047
Baton Rouge, Louisiana, United States
- Site # 001849
Baltimore, Maryland, United States
- Site # 001053
Boston, Massachusetts, United States
- Site # 001816
Roseville, Michigan, United States
- Site # 001848
Warren, Michigan, United States
- Site # 001028
Bloomington, Minnesota, United States
- Site # 001834
Eagan, Minnesota, United States
- Site # 001957
Minneapolis, Minnesota, United States
- Site # 001802
Des Peres, Missouri, United States
- Site # 001838
St Louis, Missouri, United States
- Site # 001010
Las Vegas, Nevada, United States
- Site # 001954
Reno, Nevada, United States
- Site #001961
Toms River, New Jersey, United States
- Site # 001860
Kingston, New York, United States
- Site # 001041
New York, New York, United States
- Site # 001910
New York, New York, United States
- Site # 001921
New York, New York, United States
- Site # 001034
North Syracuse, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 30 Apr 2013
- Completion
- 30 Apr 2013
- Last update posted
- 10 Apr 2015
- Registered enrollment
- 688
- Registry id
- NCT01287247
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.